Clene Inc. Rob Etherington, CEO, and Morgan Brown, CFO, to Present at the Investor Summit Virtual on March 11
Clene (CLNN) has announced its participation in the upcoming Investor Summit Virtual event scheduled for March 11, 2025. The company will be represented by two key executives: Rob Etherington, Chief Executive Officer, and Morgan Brown, Chief Financial Officer, who will be presenting at the virtual conference.
Clene (CLNN) ha annunciato la sua partecipazione al prossimo evento Investor Summit Virtual in programma per il 11 marzo 2025. L'azienda sarà rappresentata da due dirigenti chiave: Rob Etherington, Amministratore Delegato, e Morgan Brown, Direttore Finanziario, che presenteranno alla conferenza virtuale.
Clene (CLNN) ha anunciado su participación en el próximo evento Investor Summit Virtual programado para el 11 de marzo de 2025. La empresa estará representada por dos ejecutivos clave: Rob Etherington, Director Ejecutivo, y Morgan Brown, Director Financiero, quienes presentarán en la conferencia virtual.
Clene (CLNN)은 2025년 3월 11일로 예정된 Investor Summit Virtual 행사에 참여할 것이라고 발표했습니다. 이 회사는 Rob Etherington CEO와 Morgan Brown CFO 두 명의 주요 임원이 가상 회의에서 발표할 예정입니다.
Clene (CLNN) a annoncé sa participation au prochain événement Investor Summit Virtual prévu pour le 11 mars 2025. L'entreprise sera représentée par deux cadres clés : Rob Etherington, Directeur Général, et Morgan Brown, Directeur Financier, qui présenteront lors de la conférence virtuelle.
Clene (CLNN) hat seine Teilnahme an der bevorstehenden Veranstaltung Investor Summit Virtual, die für den 11. März 2025 geplant ist, angekündigt. Das Unternehmen wird von zwei wichtigen Führungskräften vertreten: Rob Etherington, Geschäftsführer, und Morgan Brown, Finanzvorstand, die auf der virtuellen Konferenz präsentieren werden.
- None.
- None.
NEW YORK, NY / ACCESS Newswire / February 27, 2025 / Rob Etherington, CEO, and Morgan Brown, CFO, of Clene Inc., will be presenting at this year's Investor Summit Virtual on March 11th.
About Clene Inc.
Clene Inc. is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson's disease, and multiple sclerosis. CNM-Au8® is an investigational first-in-class therapy that improves central nervous system cells' survival and function via a mechanism that targets mitochondrial function and the NAD pathway while reducing oxidative stress. CNM-Au8® is a federally registered trademark of Clene Nanomedicine, Inc. The company is based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland.
Event: Q1 Investor Summit
Presentation Time:1:00 PM ET
Location: https://www.webcaster4.com/Webcast/Page/3082/52092
Conference Overview and Structure
The Investor Summit is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various subject matter experts, and see what your peers are doing in this market.
This quarter's event is focused on MicroCap companies who are undervalued, have a catalyst, and are undervalued.
Registration for Investors
To request free registration, please go to our website (https://investorsummitgroup.com/), and click the "Registration" button.
Sponsors:
AccessNewswire
PCG Advisory
QuoteMedia
AGP
MZ Group
News Compliments of ACCESSWIRE NEWSWIRE
For More Information
Please visit: https://investorsummitgroup.com/
Or, contact johnna-mae@investorsummitgroup.com
SOURCE: Clene Inc.
View the original press release on ACCESS Newswire
FAQ
When is Clene (CLNN) presenting at the Investor Summit Virtual 2025?
Who will represent CLNN at the March 2025 Investor Summit Virtual?
What type of event is the Investor Summit where CLNN is presenting?
Where will the CLNN Investor Summit presentation take place?
